MSK Lymphoma SPORE 2017-2018 Developmental Research Program (DRP) Awards

Sponsor:
Hosted at Memorial Sloan Kettering Cancer Center – Funded by the National Institutes of Health

Deadline:

July 28, 2017

Summary:

This RFA is designed to support young investigators as well as established investigators focusing on basic, translational, or clinical research of lymphoma. The primary objective of this DRP Award is to support pilot projects that explore innovative ideas in basic and translational research in lymphoma. Potential topics of interest include, but are not limited to:
• Pathogenesis
• Experimental therapeutics, including mechanism based combinations, and biomarker driven treatment strategies
• Immunology and immunotherapies
• Circulating tumor DNA

Eligibility:

Investigators at Memorial Sloan Kettering Cancer Center, Rockefeller University, Weill Cornell Medical Center, Columbia University, Mount Sinai Hospital, and NYU, are eligible.
Applicants must hold academic rank of Instructor, Assistant Professor, or higher.
Applicants must possess an MD, DO or a PhD degree in a relevant area of research. The pilot projects may be collaborative among scientists within one or more SPOREs, or with scientists outside the SPORE community including the international scientific community. High risk/high payoff pilot projects are especially encouraged. These pilot projects do not need to reach a human endpoint during the project period as do full projects, including the Developmental Research Program. Letters of collaboration (if if applicable)

Proposals cannot be currently funded by an extramural agency or foundation. The budget is limited to $50K/year (direct costs. No indirect costs).

Anticipated Funding Amount:

Each year, 3-4 applications will be funded. The maximum award will be $50,000 for one year. Applicants will be funded for a maximum of two years with funding for the second year contingent on documented significant progress during the first year of funding, and peer review evaluations.

PROPOSAL PROCESS:

Proposals cannot be currently funded by an extramural agency or foundation. The budget is limited to $50K/year (direct costs. No indirect costs). Proposals must be submitted to Felicia Reid reidf@mskcc.org by July 24th, 2017.

REQUIRED INFORMATION:
Research proposals must be no longer than 5 pages (excluding budget) and should follow the format for an R01 grant application; the length of the final proposal are limited to 6 pages. The proposals will require the following standard NIH format:
Format: Applications must be in 11-point Arial. Margins must be at least 0.50 inches wide on all sides of each page.
MSK Lymphoma SPORE
2017-2018 Developmental Research Program (DRP) Awards
1) Face Page (including Title, Name of Applicant, and Names of Key Collaborators)
2) Abstract (250 words max)
3) Research Plan (5-page limit). Include the following content: Specific Aims, Preliminary Studies, and Research Strategy (a. Significance, b. Innovation, c. Approach)
6) Research environment (1 page)
7) Include up to 6 Literature Citations
8) Human Subjects or Vertebrate Animals. (Please follow the NIH guidelines)
9) NIH Biosketch for all key personnel (5 pages each in NIH-specified format)
10) Budget and Budget Justification. Include a detailed NIH-format Budget for one year totaling $50,000 direct costs. The application must include a detailed budget for the initial year, a summary budget, and a budget justification.
REVIEW CRITERIA:
All proposals will be reviewed by the scientific review committee and ad hoc reviewers, according to the following criteria, as relevant:
1. Scientific merit of the proposed project
2. Innovation
3. Approach
4. Qualifications of the investigator
5. Research environment
IRB approval (or waiver) will be required before funding if the study involves human subjects.
SCIENTIFIC REVIEW COMMITTEE:
The DRP Review Committee will include 3 ad hoc members of the SPORE Internal Advisory Board Committee, and 3 ad hoc members of the SPORE External Advisory Board Committee, and 3 additional external reviewers from other lymphoma SPORES
FUNDING CYCLES:
Awards will begin in August 2017
Authors must cite the MSK Lymphoma SPORE (P50 CA192937) in the funding acknowledgements when submitting a manuscript based on research supported, in whole or in part, by this SPORE-Developmental Research Program.
Written progress and final reports will be required at the end of funding period. Any questions regarding this solicitation should be directed to Felicia Reid reidf@mskcc.org or to the DRP directors; Dr. John Leonard jpleonar@med.cornell.edu or Dr. Anas Younes younesa@mskcc.org.
KEY DATES:
• Applications are due on July 24th, 2017
• Award Announcements by August 18th, 2017
• Award Start Date: August 30th, 2017

SUBMISSION INFORMATION:
Proposals must be submitted electronically to Felicia Reid reidf@mskcc.org. Proposals must be submitted as a compiled PDF document.
ADDITIONAL BUDGET INFORMATION: Up to $50K direct costs for one year, may be renewable for an additional year based on review
Expenditures allowed
1 Research supplies and animal maintenance.
2 Technical assistance.
3 Publication costs, including reprints.
4 Data analysis.
5 Special fees (pathology, photography, etc.).
6 Stipends for graduate students and postdoctoral fellows.
The following expenditures will not be considered:
1 Secretary or administrative personnel.
2 Office equipment or supplies.
3 Laboratory equipment or computers.
4 Tuition.
5 Foreign travel.
6 Honoraria and travel expenditures.
7 Recruitment.
8 Patient care charges (requires justification if a clinical trial is proposed).
9 Non-medical or personal services to patients.

SFARI Explorer Awards

Sponsor:

Simons Foundation Autism Research Initiative (SFARI)

Deadline:

Applications are considered on a rolling basis, with a response time as early as 30 days.

Summary:

This award program is designed to enhance our existing support of autism research by providing timely resources to enable focused experiments highly relevant to our mission. A deeper understanding of the mechanisms underlying autism spectrum disorders or potential therapeutic approaches will require investigation at multiple levels, including but not limited to studies focused on gene discovery, molecular mechanisms, circuits, anatomy, and cognition and behavior. We will consider proposals at all of these levels.

Explorer Awards are intended to provide resources to support exploratory experiments that will strengthen hypotheses and lead to the formulation of competitive applications for subsequent larger-scale funding by SFARI or other organizations. Innovative, high-risk/high-impact proposals are encouraged. We especially encourage applications from investigators who are new to the field of autism, but who have expertise that could be brought to bear on this complex disorder.

Eligibility:

All applicants and key collaborators must hold a Ph.D., M.D. or equivalent degree and have a faculty position or the equivalent at a college, university, medical school or other research facility. Applications may be submitted by domestic and foreign nonprofit organizations; public and private institutions, such as colleges, universities, hospitals, laboratories, units of state and local government; and eligible agencies of the federal government. There are no citizenship or country requirements.

Available Funding:

The maximum budget is $70,000, including indirect costs for one (1) year, non-renewable.

Link to Full RFP:

https://sfari.org/funding/grants/explorer-awards-rfa

Integration of Individual Residential Histories into Cancer Research (R21) PA-17-295 and (R01) PA-17-298

Sponsor:

NIH / NCI

Deadline:

Standard R01 dates apply

Standard R21 dates apply

Summary:

The purpose of this Funding Opportunity Announcement (FOA) is to support substantive investigation of the role of individual residential histories in cancer etiology and outcomes, and to encourage the development of complex analytical strategies in support of substantive investigation.

There is a growing recognition of the importance of residential histories – a record of an individual’s places of residence across his or her lifetime — in cancer research, as part of evolving cancer data ecosystem.  Residential history encapsulates a person’s multiple interactions with the social and physical environment that can result in lasting health impact and is an important factor in assessing the effects of exposures on disease onset, as demonstrated in focused studies.  Lifetime residential history records can reveal the variety of potential and actual exposures throughout person’s life including, but not limited to: neighborhood characteristics, physical conditions of housing, tobacco and alcohol consumption, food environments, chemical exposures to contaminants in water, soil, and air, accessibility to healthcare resources, and health disparities.

This FOA is expected to engage scientists from a range of disciplines, including epidemiology, statistics, geospatial science, computer science, demography, decision science, and behavioral science, to effectively integrate individual residential histories into cancer research.

Geospatial expertise is essential for generating new knowledge about the residential context relative to cancer risk, etiology, prevention, treatment, and outcomes. Computer science and informatics are crucial for the development of methodology that would ensure more precise matching of residential information and location (geocoding), improve linkage to automated data sources, and generate reliable lifetime residential histories. Cancer surveillance science, in conjunction with statistical, epidemiological, and medical expertise, is extremely important in answering substantial questions related to the use of lifetime residential histories in the analysis of cancer risk and cancer burden.

In addition, a combination of scientific expertise in demography and behavioral science in addressing the role of lifetime residential histories in the context of cancer can help facilitate more precise assessment of cancer disparities.

Eligibility:

N/A

Available Funding:

R01: Application budgets are not limited but need to reflect the actual needs of the proposed project. The maximum project period is 5 years.

R21: The combined budget for direct costs for the two-year project period may not exceed $275,000. No more than $200,000 may be requested in a single year. The maximum project period is 2 years.

Link to Full RFP:

R01https://grants.nih.gov/grants/guide/pa-files/PA-17-298.html

R21https://grants.nih.gov/grants/guide/pa-files/PA-17-295.html

Centers for Chemical Innovation – Phase I (CCI) (NSF 17-564)

Sponsor:

National Science Foundation

Deadline:

Preliminary Proposals: September 12, 2017

Full Proposals (by invitation only): March 06, 2018

Summary:

The Centers for Chemical Innovation (CCI) Program supports research centers focused on major, long-term fundamental chemical research challenges. CCIs are agile structures that respond rapidly to emerging opportunities, promote synergy, enhance collaborations, and engage in potentially transformative research. CCIs integrate research, innovation, education, broadening participation, and informal science communication.

The FY 2018 Phase I CCI competition is open to projects in all fields supported by the Division of Chemistry. Successful proposals will have a clear chemistry focus and the potential for transformative impact in chemistry. The Division of Chemistry particularly encourages CCI centers or projects within centers aligned with Data-Driven Discovery Science in Chemistry (D3SC). Such CCI projects would seek new chemical understanding through sharing, mining and repurposing of chemical datasets and through the use of state-of-the-art data analysis techniques. Additional context for D3SC and links to related documents can be found at NSF 17-036.

The research activities may build on pre-existing efforts, but new, collaborative results attributed to the CCI award are expected. The Phase I award will also develop broader impact activities in the four required areas (see below), including piloting and developing center-scale activities commensurate with a Phase II CCI. Center development includes the development of a strategic plan covering all aspects of a CCI (see full RFP).

CCIs are expected to integrate their research with activities that broaden the impact of their research. A Phase I team might pilot activities in these areas:

  • Innovation – translation or transfer of basic research results into economic or societal benefit. This element includes intellectual property protection and a proactive plan to either engage industry in technology transfer or to commercialize technology in other ways.
  • Higher Education and Professional Development – education and professional development for undergraduate and graduate students supported by the grant, including co-mentorship or other collaborative training and continued professional development and mentoring for postdoctoral research associates. This may also include education in various aspects of innovation (intellectual property, entrepreneurship, etc.) and other higher education activities (i.e., new course materials or curricula).
  • Broadening the participation of underrepresented groups – CCI goals for increasing engagement by underrepresented groups, plans for reaching those goals, and an evaluation strategy.
  • Informal science communication – plans for communicating the CCI research to public audiences and possible ways to evaluate the impact of these outreach efforts.

Eligibility:

Who May Serve as PI:

  • While these proposals will reflect the research of many investigators, only the name of the Principal Investigator (PI) should appear on the cover sheet. All other investigators are considered Faculty Associates (non-coPI senior personnel). An investigator may participate (as PI or Faculty Associate) in only one CCI preliminary proposal and one CCI full proposal (Phase I or Phase II) submitted to this competition. The PI must be affiliated with an eligible submitting organization.

Limit on Number of Proposals per PI or Co-PI: 1

  • An investigator may participate (as PI or Faculty Associate) in only one preliminary proposal and one full proposal (Phase I or Phase II) submitted in response to this solicitation. The PI must be affiliated with an eligible submitting organization.

The team of investigators for a Phase I proposal must include at least four senior researchers with complementary expertise. While there is no upper limit on the number of Phase I investigators, proposers are cautioned to avoid teams that are too large to collaborate effectively. The available resources should also be carefully considered in assembling the team. CCIs may partner with researchers from industry, national laboratories and international organizations. See detailed guidance below for non-U.S. or non-academic researchers.

Available Funding:

NSF anticipates making three new Phase I awards (up to $1,800,000 for 3 years) as standard or continuing grants.

Link to Full RFP:

https://www.nsf.gov/pubs/2017/nsf17564/nsf17564.htm?WT.mc_id=USNSF_25&WT.mc_ev=click#elig

ONR Young Investigator Program

Sponsor:

Office of Naval Research

Deadline:

September 15, 2017

Summary:

The Office of Naval Research (ONR) is interested in receiving proposals for its Young Investigator Program (YIP). ONR’s Young Investigator Program (YIP) seeks to identify and support academic scientists and engineers who are in their first or second full-time tenure-track or tenure-trackequivalent academic appointment, have begun their first appointment on or after 31 December 2012, and who show exceptional promise for doing creative research. The objectives of this program are to attract outstanding faculty members of Institutions of Higher Education (hereafter also called “universities”) to the Department of the Navy’s Science and Technology (S&T) research program, to support their research, and to encourage their teaching and research careers.

Proposals addressing research areas (as described in the ONR Science and Technology Department section of ONR’s website at www.onr.navy.mil) which are of interest to ONR program officers will be considered. Contact information for each division (a subgroup of an S&T Department) is also listed within the S&T section of the website.

Eligibility:

The Principal Investigator of a proposal must be a U.S. citizen, national, or permanent resident (on the date proposals are due), holding a first or second full-time tenure-track or tenure-track-equivalentfaculty position at that university, and has begun her/his first full-time appointment on or after 31 December 2012.

Available Funding:

Applicants may request up to $170,000 per year for three (3) years. (Additional funds for capital equipment which enhances the Young Investigator’s proposed research may be requested.)

Link to Full RFP:

https://www.grants.gov/custom/viewOppDetails.jsp?oppId=294449

SFARI Bridge to Independence Award Request for Applications

Sponsor:

Simons Foundation Autism Research Initiative (SFARI)

Deadline:

August 7, 2017

Summary:

The Simons Foundation Autism Research Initiative (SFARI) seeks to improve the understanding, diagnosis and treatment of autism spectrum disorders by funding innovative research of the highest quality and relevance.  In order to sustain this level of scientific excellence in future years, SFARI is extending our support to promising early-career investigators.

Grants awarded through the Bridge to Independence Award program are intended to invest in the next generation of top autism investigators by identifying talented early-career scientists interested in autism research and facilitating their transition to an independent research career. This request for applications (RFA) is aimed at senior postdoctoral fellows who intend to seek tenure-track faculty positions during the 2017–18 academic year. Successful applicants will be notified that they are finalists in the Bridge to Independence Award program and will have one year to submit an approval application, which includes confirmation of a tenure-track professorship at a U.S. academic institution, review of the institution’s research environment and resources, and institutional signoff.

Eligibility:

  • Applicants must hold a Ph.D., M.D. or equivalent degree
  • Applicants must have fewer than six (6) years of postdoctoral or otherwise mentored training.
  • Applicants must be currently in non-independent, mentored, training positions, as recognized by their institution. The following guidelines should be used to distinguish independent from non-independent positions (modified from NIH’s K99/R00 Program Announcement eligibility section): Evidence for non-independence may include:
  • The applicant’s research is entirely funded by another investigator’s grants.
  • The applicant’s research is conducted entirely in another investigator’s assigned space.
  • According to institutional policy, the applicant is not allowed to submit an application for an NIH research grant (e.g., R01) or SFARI grant (e.g, Explorer, Pilot, Research, and Targeted awards.)
  • Applicants must be actively seeking a tenure-track position at a U.S. institution of higher education during 2017-18 academic year.
  • Applicants are not eligible if they are recipients of other career development awards with similar budgetary scope as the SFARI Bridge to Independence award. These include, but are not limited to:
    • NIH K99/R00 (please note that other K awardees may be eligible, e.g., K01 and K08)
    • Burroughs-Wellcome Fund Career Award for Medical Scientists
    • American Academy of Neurology Career Development Award
    • Howard Hughes Medical Institute Hanna H. Gray fellowship

You are strongly encouraged to contact SFARI prior to grant submission if you believe your career development award is comparable to the BTI award but is not listed above.

  • Applicants must not have accepted a formal offer for a tenure-track faculty position.
  • There are no citizenship requirements.

Available Funding:

The principal investigator (PI) will receive research support at a fixed rate of $150,000 per year, including 20 percent for indirect costs (see SFARI policies), for up to three (3) years. Funds may not be used toward the PI’s salary but may provide salary support for other laboratory personnel. Institutional start-up packages may not be reduced because of SFARI funding.

Link to Full RFP:

https://sfari.org/funding/grants/bridge-to-independence-rfa/bridge-to-independence-award-request-for-applications

Socioeconomic Disparities in Health and Mortality at Older Ages (R01) (RFA-AG-18-011)

Sponsor:

National Institute on Aging

Deadline:

October 20, 2017

Summary:

The purpose of this funding opportunity is to support studies that identify mechanisms, explanations, and modifiable risk factors underlying recent trends of growing inequalities in morbidity and mortality by income, education, and geographic location at older ages in the United States. Applicants are encouraged to consider a variety of health outcomes in order to explain the processes generating these trends. Applicants are strongly encouraged to present well-developed conceptual models.

Examples of analytic approaches that fall within the scope of this FOA include (but are not limited to) those that:

  • Identify the mechanisms that explain growing socioeconomic and geographic inequalities in health at older ages, explain their role in racial disparities, and detect modifiable risk factors
  • Ascertain the extent to which these trends are driven by age, period, and cohort-related factors
  • Consider the role of education, income, and geographic region as causal factors versus alternative explanations such as differential selection over time or shifting composition of groups
  • Leverage longitudinal data, ideally from childhood through old age
  • Use a diverse set of analytic methods (e.g. life-cycle, comparative, cohort, multi-level)
  • Consider how institutional and cultural contexts (including their timing within the life course of individuals) influence health disparities
  • Examine a wide range of physical, mental, and functional health outcomes, in addition to mortality
  • Capitalize on NIA-funded data sources with life history and geographic information (e.g., English Longitudinal Study of Ageing; Health and Retirement Study; Midlife in the United States; National Longitudinal Mortality Study; Panel Study of Income Dynamics; Survey of Health, Ageing, and Retirement in Europe)

Examples of data improvements that fall within the scope of this FOA include (but are not limited to) those that:

  • Enhance existing data resources to improve data availability on a variety of topics (e.g., early life development, exposures to inequality prior to midlife, comprehensive stress measurements, employer and work issues, and minority groups) to enable examination of within-group heterogeneity
  • Enhance existing clinical studies to add complementary measures in areas such as social, emotional, and psychological domains

Characteristics of Responsive Applications

1. Life course approaches are encouraged, but applications proposing analysis of data solely from childhood or young adulthood are not responsive to this FOA.

2. Applications that document descriptive trends without assessing potential mechanisms or explanations will not be considered responsive.

3. Applications proposing projects that use only animal models are not responsive to this FOA. 

Eligibility:

Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.

For institutions/organizations proposing multiple PDs/PIs, visit the Multiple Program Director/Principal Investigator Policy and submission details in the Senior/Key Person Profile (Expanded) Component of the SF424 (R&R) Application Guide.

Available Funding:

The National Institute on Aging intends to commit $2 million in total costs in FY 2018 to fund 3-6 awards. The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Link to Full RFP:

https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-18-011.html

Multi-discipline and Systemic Caring for the Woman Experiencing Menopause: Innovative Decision Making Tools

Sponsor:

Pfizer Independent Grants for Learning & Change

Deadline:

July 12, 2017

Summary:

Pfizer Global Medical Grants seeks to support innovative educational programming to support optimal and/or appropriate practice interventions regarding care and treatment of women experiencing menopause. Projects should focus on educational resources (e.g. patient-physician shared decision-making tools /innovative apps) to support effective identification of the need for therapeutic intervention and appropriate selection of therapeutic intervention based on presentation.

  • The learning and change strategy should address helping improve the care of women with menopause by:
  • Improving symptom identification (by patients or physicians)
  • Improving care systems that showcase and operationalize the wellness visit as a focus for menopausal care

Innovating patient-physician awareness of various treatment options and modalities for appropriate patients and with appropriate risk-balance assessment The educational initiative should be focused on primary care practitioners, nurse practitioners, physician assistants, obstetricians and gynecologists, and all other specialists who care for the menopausal woman. Proposals whose educational model is broadly applicable for use in other settings and/or used for resident education will be rated favorably.

In addition, proposals that include the following elements are of interest:

  • Completed within a 12 month timeframe
  • Developing durable tools, materials (e.g. >1 one time use)
  • Intraprofessional collaboration among organizations
  • Incorporating the patient perspective
  • Innovative in terms of approach and output
  • Robust outcomes plan that reflects optimization of care metrics

The utilization of multiple forms of innovation, such as digital communication or social media, to reach the intended audience and to measure change in comprehension and intent to apply learning in practice are critical parts of a successful grant.

Projects that focus on live annual meetings, regional conferences, and speaker series are out of scope.

Eligibility:

Project  must be based in the United States.

The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional associations and medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement.

Collaborations within institutions (e.g., between departments and/or inter-professional), as well as between different institutions/organizations/associations, or even different disciplines are encouraged. All partners must have a relevant role, and the requesting organization must have a leadership role.

Available Funding:

Individual projects requesting up to $200,000 will be considered.

Link to Full RFP:

http://www.pfizer.com/files/IGLC_CGA17WH2_MenopausalCare.v.2.pdf

Addressing Attitudes, Beliefs, and Cultural Barriers in Women’s Health Decision-Making

Sponsor:

Pfizer Independent Grants for Learning & Change (IGLC)

Deadline:

July 26, 2017

Summary:

Pfizer Global Medical Grants seeks to support innovative educational programming to understand the role of patient attitudes, beliefs, and cultural barriers in women’s health decision-making during reproductive and post-reproductive health care. These factors have a major influence and variations exist globally for women during life events including family planning and menopause related issues. The learning and change strategy should address techniques to overcome barriers in improving the care of women during family planning and/or menopause by:

  • Improving care systems that showcase and operationalize the wellness visit
  • Innovating the patient-physician dialogue (e.g. ‘difficult conversations’)
  • Innovating patient-physician awareness of various treatment options and modalities for appropriate patients and with appropriate risk-balance assessment
  • Dispelling common patient myths and misconceptions.

The educational initiative should be focused on primary care practitioners including general practitioners, nurse practitioners, physician assistants, obstetricians and gynecologists, and/or other specialists who care for women in the reproductive phase of their lives, menopausal women, or all. Proposals whose educational model is broadly applicable for use in varied settings and/or used for trainee education will be rated favorably.

The utilization of multiple forms of innovation, such as digital communication or social media, to reach the intended audience and to measure change in comprehension and intent to apply learning in practice are critical parts of a successful grant.  

Eligibility:

Project must be global in scope.

The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional associations and medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement.

Collaborations within institutions (e.g., between departments and/or inter-professional), as well as between different institutions/organizations/associations, or even different disciplines are encouraged. All partners must have a relevant role, and the requesting organization must have a leadership role.

Available Funding:

Individual projects requesting up to $200,000 will be considered.

Link to Full RFP:

http://www.pfizer.com/files/IGLC_CGA17WH1_WomensHealth.v.2.pdf

Addressing Education in Relation to Tobacco Dependence Treatment in France

Sponsor:

Pfizer Independent Grants for Learning & Change (IGLC)

Deadline:

July 31, 2017

Summary:

It is our intent to support programs that strive to increase the number of patients who stop smoking by improving the frequency and effectiveness of healthcare professional smoking cessation interventions. This CGA is to encourage academic and healthcare organisations to submit applications focused on educating healthcare professionals on the latest clinical data-driven updates in tobacco dependence treatments. Applications focusing on one or more of the following criteria will be given preference:

  • Educating physicians to initiate smoking cessation discussions with patients and to promote the health benefits of smoking cessation
  • Educating physicians about the importance of initiating smoking cessation therapy
  • Increasing physician awareness of the available treatment and support mechanisms required for smoking cessation
  • Educating physicians about the importance of ensuring appropriate follow-up with patients following initiation of smoking cessation treatment/counselling to ensure compliance

While programming targeted at addressing knowledge gaps may involve live sessions, efforts should be made to encourage interaction and provide opportunities to extend learning opportunities beyond the live setting. In addition to live programs, technology-enabled distance learning with facilitated interactive components, online courses, and other enduring materials may also be proposed.

Eligibility:

Geographic scope is France only.

The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional associations and medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement. However, please note that priority will be given to applications from non-profit academic and healthcare organisations.

Collaborations within institutions (e.g., between departments and/or inter-professional), as well as between different institutions/organizations/associations, or even different disciplines are encouraged. All partners must have a relevant role, and the requesting organization must have a leadership role.

Available Funding:

Individual projects requesting up to $50,000 will be considered. The total available budget related to this CGA is $150,000.

Link to Full RFP:

http://www.pfizer.com/files/IGLC_CGA17SC1_SmokingCessation.pdf